The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
U.S. Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions To Reduce Perinatal HIV-1 Transmission in the United States: (548362006-001)
Abstract
These recommendations update the February 4,2002, guidelines developed by the Public Health Service for the use of zidovudine (ZDV) to reduce the risk for perinatal human immunodeficiency virus type 1 (HIV-1) transmission. This report provides healthcare providers with information for discussion with HIV-1-infected pregnant women to enable such women to make an informed decision regarding the use of antiretroviral drugs during pregnancy and use of elective cesarean delivery to reduce perinatal HIV-1 transmission. Various circumstances that commonly occur in clinical practice are presented, and the factors influencing treatment considerations are highlighted in this report. The Perinatal HIV Guidelines Working Group recognizes that strategies to prevent perinatal transmission and concepts related to management of HIV disease in pregnant women are rapidly evolving and will continually review new data and provide regular updates to the guidelines. The most recent information is available from the HIV/AIDS Treatment Information Service (available at http.//www.hivatis.org). In February 1994, the results of Pediatric AIDS Clinical Trials Group (PACTG) Protocol 076 documented that ZDV chemoprophylaxis could reduce perinatal HIV-1 transmission by nearly 70%. Epidemiologic data have since confirmed the efficacy of ZDV for reduction of perinatal transmission and have extended this efficacy to children of women with advanced disease, low CD4+ T-lymphocyte counts, and prior ZDV therapy. Additionally, substantial advances have been made in the understanding of the pathogenesis of HIV-1 infection and in the treatment and monitoring of persons with HIV-1 disease. These advances have resulted in changes in standard antiretroviral therapy for HIV-1-infected adults. More aggressive combination drug regimens that maximally suppress viral replication are now recommended. Although considerations associated with pregnancy may affect decisions regarding timing and choice of therapy pregnancy is not a reason to defer standard therapy. Use of antiretroviral drugs in pregnancy requires unique considerations, including the possible need to alter dosage as a result of physiologic changes associated with pregnancy the potential for adverse short- or long-term effects on the fetus and newborn, and the effectiveness of the drugs in reducing the risk for perinatal transmission. Data to address many of these considerations are not yet available. Therefore, offering antiretroviral therapy to HIV-1-infected women during pregnancy, whether primarily for HIV-1 infection, for reduction of perinatal transmission, or for both purposes, should be accompanied by a discussion of the known and unknown short- and long-term benefits and risks of such therapy to infected women and their infants. Standard antiretroviral therapy should be discussed with and offered to HIV-1-infected pregnant women. Additionally, to prevent perinatal transmission, ZDV chemoprophylaxis should be incorporated into the antiretroviral regimen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Connor, E. M., Sperling, R. S., Gelber, R., Kiselev, P., Scott, G., O'Sullivan, M. J., VanDyke, R., Bey, M., Shearer, W., Jacobson, R. L., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311801 · Cited by 3,705
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,885
Cooper, E. R., Charurat, M., Mofenson, L., Hanson, I. C., Pitt, J., Diaz, C., Hayani, K., Handelsman, E., Smeriglio, V., Hoff, R., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204150-00009 · Cited by 1,058
Sperling, R. S., Shapiro, D. E., Coombs, R. W., Todd, J. A., Herman, S. A., McSherry, G. D., O'Sullivan, M. J., Van Dyke, R. B., Jimenez, E., Rouzioux, C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352201 · Cited by 803
Garcia, P. M., Kalish, L. A., Pitt, J., Minkoff, H., Quinn, T. C., Burchett, S. K., Kornegay, J., Jackson, B., Moye, J., Hanson, C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410602 · Cited by 790
Shaffer, N., Chuachoowong, R., Mock, P. A., Bhadrakom, C., Siriwasin, W., Young, N. L., Chotpitayasunondh, T., Chearskul, S., Roongpisuthipong, A., Chinayon, P., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10411-7 · Cited by 785
Hirsch, M. S., Brun-Vézinet, F., D'Aquila, R. T., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Loveday, C., Mellors, J. W., Clotet, B., Conway, B., et al. (2000) · JAMA · doi:10.1001/jama.283.18.2417 · Cited by 766
Comparison of a Trial of Labor with an Elective Second Cesarean Section
McMahon, M. J., Luther, E. R., Bowes, W. A., & Olshan, A. F. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609053351001 · Cited by 700
Prevention of SIV Infection in Macaques by ( R )-9-(2-Phosphonylmethoxypropyl)adenine
Tsai, C.-C., Follis, K. E., Sabo, A., Beck, T. W., Grant, R. F., Bischofberger, N., Benveniste, R. E., & Black, R. (1995) · Science · doi:10.1126/science.270.5239.1197 · Cited by 563
Wade, N. A., Birkhead, G. S., Warren, B. L., Charbonneau, T. T., French, P. T., Wang, L., Baum, J. B., Tesoriero, J. M., & Savicki, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811123392001 · Cited by 535
Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance
Wainberg, M. A. (1998) · JAMA · doi:10.1001/jama.279.24.1977 · Cited by 498
A Fetal Fatty-Acid Oxidation Disorder as a Cause of Liver Disease in Pregnant Women
Ibdah, J. A., Bennett, M. J., Rinaldo, P., Zhao, Y., Gibson, B., Sims, H. F., & Strauss, A. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402204 · Cited by 496
HIV-1 Drug Resistance in Newly Infected Individuals
Boden, D. (1999) · JAMA · doi:10.1001/jama.282.12.1135 · Cited by 466
Brocklehurst, P., & French, R. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10227.x · Cited by 461
(2002) · The Lancet · doi:10.1016/s0140-6736(02)08214-4 · Cited by 459
Lallemant, M., Jourdain, G., Le Coeur, S., Kim, S., Koetsawang, S., Comeau, A. M., Phoolcharoen, W., Essex, M., McIntosh, K., & Vithayasai, V. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431401 · Cited by 425
Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV Infection
Little, S. J. (1999) · JAMA · doi:10.1001/jama.282.12.1142 · Cited by 335
Havlir, D. V. (2000) · JAMA · doi:10.1001/jama.283.2.229 · Cited by 297
Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects
Lorenzi, P., Spicher, V. M., Laubereau, B., Hirschel, B. J., Kind, C., Rudin, C., Irion, O. P., & Kaiser, L. (1998) · AIDS · doi:10.1097/00002030-199818000-00002 · Cited by 282
Olivero, O. A., Yuspa, S. H., Poirier, M. C., Anderson, L. M., Jones, A. B., Wang, C., Diwan, B. A., Haines, D. C., Logsdon, D., Harbaugh, S. W., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1602 · Cited by 225
Cooper, D. A., Gatell, J. M., Kroon, S., Clumeck, N., Millard, J., Goebel, F.-D., Bruun, J. N., Stingl, G., Melville, R. L., Gonzalez-Lahoz, J., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290501 · Cited by 216
Viral Dynamics of HIV: Implications for Drug Development and Therapeutic Strategies
Havlir, D. V., & Richman, D. D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-11-199606010-00006 · Cited by 204
Lumpkin, M. M. (1998) · Anesthesiology · doi:10.1097/00000542-199802000-00001 · Cited by 197
Is, F., Belitsos, P. C., Chaisson, R. E., & Moore, R. D. (1995) · PubMed · Cited by 188
Saravolatz, L. D., Winslow, D. L., Collins, G., Hodges, J. S., Pettinelli, C., Stein, D. S., Markowitz, N., Reves, R., Loveless, M. O., Crane, L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351503 · Cited by 175
Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one
Study, T. E. C. (1999) · AIDS · doi:10.1097/00002030-199907300-00016 · Cited by 175
Fiscus, S. A. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530430027034 · Cited by 168
Postoperative cesarean section morbidity: A prospective study
Nielsen, T. F., & Hökegård, K.-H. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90963-8 · Cited by 161
Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand
Mock, P. A., Shaffer, N., Bhadrakom, C., Siriwasin, W., Chotpitayasunondh, T., Chearskul, S., Young, N. L., Roongpisuthipong, A., Chinayon, P., Kalish, M. L., et al. (1999) · AIDS · doi:10.1097/00002030-199902250-00014 · Cited by 156
Eastman, P. S., Shapiro, D. E., Coombs, R. W., Frenkel, L. M., McSherry, G., Britto, P., Herman, S. A., & SPERLING, R. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/514228 · Cited by 151
Cunningham, C. K., Chaix, M., Rekacewicz, C., Britto, P., Rouzioux, C., Gelber, R. D., Dorenbaum, A., Delfraissy, J. F., Bazin, B., MOFENSON, L. M., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/341300 · Cited by 137
Serious maternal morbidity after childbirth: prolonged hospital stays and readmissions
Hebert, P. R. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00419-6 · Cited by 134
Severe Diabetes Associated with Protease Inhibitor Therapy
Visnegarwala, F., Krause, K. L., & Musher, D. M. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00016 · Cited by 134
Shaffer, N., Roongpisuthipong, A., Siriwasin, W., Chotpitayasunondh, T., Chearskul, S., Young, N. L., Parekh, B., Mock, P. A., Bhadrakom, C., Chinayon, P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314641 · Cited by 126
Maternal and infant complications in high and normal weight infants by method of delivery*1
Gregory, K. D. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00224-5 · Cited by 123
New-Onset Diabetes Mellitus Associated with Use of Protease Inhibitor
Eastone, J. A., & Decker, C. F. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00017 · Cited by 121
Cigarette Smoking and Maternal-Child HIV Transmission
Turner, B. J., Hauck, W. W., Fanning, T. R., & Markson, L. E. (1997) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199704010-00004 · Cited by 119
Liver Disease in Pregnancy and Fetal Fatty Acid Oxidation Defects
Ibdah, J. A., Yang, Z. F., & Bennett, M. J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3065 · Cited by 113
Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992–1994
Leroy, V., Ladner, J., Nyiraziraje, M., Clercq, A. D., Bazubagira, A., de Perre, P. V., Karita, E., & Dabis, F. (1998) · AIDS · doi:10.1097/00002030-199806000-00014 · Cited by 112
Antiretroviral therapy for pregnant women
MINKOFF, H. L., & Augenbraun, M. H. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70519-2 · Cited by 101
Pregnancy outcomes by mode of delivery among term breech births: swedish experience 1987–1993
Roman, J. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00326-3 · Cited by 83
Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers
Martin, R. J., Boyer, P. J. J., Hammill, H., PEAVY, H. H., Platzker, A. C. G., Settlage, R. E., Shah, A., SPERLING, R. S., TUOMALA, R. E., & Wu, M. S. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70032-5 · Cited by 68
Zhang, H., Dornadula, G., Wu, Y., Havlir, D. V., Richman, D. D., & Pomerantz, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.628-634.1996 · Cited by 48
Metabolism of 3′-azido-3′-deoxythymidine (AZT) in human placentae trophoblasts and Hofbauer cells
Qian, M., Bui, T., Ho, R. J. Y., & Unadkat, J. D. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90111-2 · Cited by 45
Peter, K., & Gambertoglio, J. G. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90132-0 · Cited by 35
Transfer and metabolism of dideoxyinosine by the perfused human placenta.
Dancis, J., Lee, J. D., Mendoza, S., & Liebes, L. (1993) · PubMed · Cited by 31
Cited by
Aberg, J. A., Kaplan, J. E., Libman, H., Emmanuel, P., Anderson, J. R., Stone, V. E., Oleske, J. M., Currier, J. S., & Gallant, J. E. (2009) · Clinical Infectious Diseases · doi:10.1086/605292 · Cited by 837
Yeni, P. G., Hammer, S. M., Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., et al. (2002) · JAMA · doi:10.1001/jama.288.2.222 · Cited by 709
Jackson, J. B., Musoke, P., Fleming, T., Guay, L. A., Bagenda, D., Allen, M., Nakabiito, C., Sherman, J., Bakaki, P., Owor, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14341-3 · Cited by 524
Antiretroviral Regimens in Pregnancy and Breast-Feeding in Botswana
Shapiro, R. L., Hughes, M. D., Ogwu, A., Kitch, D., Lockman, S., Moffat, C., Makhema, J., Moyo, S., Thior, I., McIntosh, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907736 · Cited by 521
Hirsch, M. S., Brun‐Vezinet, F., Clotet, B., Conway, B., Kuritzkes, D. R., D’Aquila, R. T., Demeter, L. M., Hammer, S. M., Johnson, V. A., Loveday, C., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375597 · Cited by 514
Metadata
- Venue
- PsycEXTRA Dataset
- Published
- 2002
- Volume
- 51
- Issue
- RR-18
- Pages
- 1-38; quiz CE1
- OpenAlex
- W1572621932
- Cited by
- 517
- References
- 49
- Type
- dataset
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.